Temporary Research Associate
Jobs at:FHI 360
Deadline of this Job:
03 June 2021
Within Uganda , Kampala , East Africa
Date Posted: Monday, May 31, 2021 , Base Salary: Not Disclosed
FHI 360 is a nonprofit human development organization dedicated to improving lives in lasting ways by advancing integrated, locally driven solutions. Our staff includes experts in health, education, nutrition, environment, economic development, civil society, gender, youth, research and technology — creating a unique mix of capabilities to address today's interrelated development challenges.
FHI 360 serves more than 70 countries.
Title: Temporary Research Associate (1 position)
Duration: 30 working Days
Location: Country Office Uganda with travel upcountry
Supervisor: Technical Advisor, Research Utilization-GHPR
Over many years of research, FHI 360 has generated substantive and convincing data showing that the doses of depot medroxyprogesterone acetate (DMPA) are greater than necessary to provide highly effective contraception for the labeled 3-month duration. The existing pharmacokinetic (serum MPA levels) and pharmacodynamic (suppression of ovulation) evidence supports the duration of effectiveness of the current subcutaneous 104 mg DMPA formulation (DMPA-SC) beyond three months. Extending the reinjection interval of DMPA-SC from 3 to 4 months (making it a 3-times-per-year product) would reduce long-term MPA exposure by 25% and reduce risk of accumulation, which would potentially shorten the delay in return to ovulation and fertility and reduce other dose-dependent side effects. Extending re-injection could also improve access to DMPA-SC in resource-constrained settings by reducing programmatic costs and opportunity costs, such as travel expenses, for users.
With support from the Children’s Investment Fund Foundation (CIFF), FHI Partners, LLC, a nonprofit subsidiary of FHI 360 is conducting several activities to establish the evidence base for and support the registration of a generic DMPA-SC as a 4-month product in Uganda and Nigeria. The availability of such a product has the potential to improve consumer experience with a significantly lower dose, offer procurement savings that could grow to $10M per year, and alleviate supply chain bottlenecks faced with the current manufacture of Sayana Press® .
FHI 360 in Uganda will in this regard implement the “Market Research on Service Delivery Implications for a 4-month Depot Medroxyprogesterone Acetate Subcutaneous (DMPA-SC) Product”. It is designed as Rapid qualitative market research, including in-depth interviews (IDIs) and focus group (FGD) discussions with key informants (KIs) including (MOH staff, family planning program implementers/providers, and private sector stakeholders) at the national and district levels likely to be involved in the introduction of a 4-month DMPA-SC product.
The study is to be implemented in the areas of Kampala and Luwero. The Research Associate will support the Site Coordinator in all matters towards successful implementation of the study.
Education Requirement: No Requirements
Job Experience: No Requirements
Work Hours: 8
Job application procedure
Interested and qualified individuals should send their applications and CV clearly stating their names and job title in the subject line to [email protected]